Cellectis (CLLS) EBT Margin (2015 - 2026)
Cellectis (CLLS) posted quarterly EBT Margin of 152.85% for Q1 2026, down 17504.0% year-over-year from N/an in Q1 2025, and up 81.67% quarter-over-quarter from 834.05% in Q4 2025.
Powered by 
Analysis
Cellectis (CLLS) EBT Margin (2015 - 2026) Analysis & Trends
Cellectis' EBT Margin history runs 12 years deep, the most recent figure standing at 152.85% for Q1 2026.
- In Q1 2026, EBT Margin fell 17504.0% year-over-year to 152.85%; the TTM figure through Mar 2026 stood at 109.14% (down 597.0% YoY), while the FY2025 annual figure was 93.24%, down 1855.0% from the prior year.
- EBT Margin for Q1 2026 stood at 152.85%, up from 834.05% in the prior quarter.
- The five-year high for EBT Margin was 1743.26% in Q2 2023, with the low at 25056.13% in Q3 2023.
- The 5-year median for EBT Margin is 203.95% (2024), against an average of 3107.32%.
- The sharpest annual moves came in 2022 and 2024: EBT Margin slumped 1281825 bps in 2022, then surged 2510367 bps in 2024.
- Cellectis' EBT Margin stood at 17.7% in 2022, then slumped by 5597 bps to 1008.6% in 2023, then surged by 80 bps to 203.95% in 2024, then tumbled by 309 bps to 834.05% in 2025, then soared by 82 bps to 152.85% in 2026.
- Business Quant data shows CLLS's EBT Margin at 152.85% in Q1 2026, 834.05% in Q4 2025, and 63.72% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | -301.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -301.61% |
| Mar 31, 2026 | -152.85% |
| Dec 31, 2025 | -30.91% |
| Sep 30, 2025 | 63.72% |
| Jun 30, 2025 | 93.60% |
| Mar 31, 2025 | 22.20% |
| Dec 31, 2024 | -301.17% |
| Sep 30, 2024 | 18.04% |
| Jun 30, 2024 | -316.34% |
| Mar 31, 2024 | 257.33% |
| Dec 31, 2023 | -41,719.43% |
| Sep 30, 2023 | -420.65% |
| Jun 30, 2023 | 2,660.67% |
| Mar 31, 2023 | -15,741.73% |
| Dec 31, 2022 | -17.70% |
| Sep 30, 2022 | -13,354.29% |
| Jun 30, 2022 | -1,454.63% |
| Mar 31, 2022 | -337.48% |
| Dec 31, 2021 | -68.77% |
| Sep 30, 2021 | -509.72% |